Shannon, A. B., Straker, R. J., Carr, M. J., Sun, J., Landa, K., Baecher, K., … Miura, J. T. (2022). ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Ann Surg Oncol, 29(11), 7045–7046. https://doi.org/10.1245/s10434-022-12293-7

Shannon, Adrienne B., Richard J. Straker, Michael J. Carr, James Sun, Karenia Landa, Kirsten Baecher, Kevin Lynch, et al. “ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.” Ann Surg Oncol 29, no. 11 (October 2022): 7045–46. https://doi.org/10.1245/s10434-022-12293-7.

Shannon AB, Straker RJ, Carr MJ, Sun J, Landa K, Baecher K, et al. ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Ann Surg Oncol. 2022 Oct;29(11):7045–6.

Shannon, Adrienne B., et al. “ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.” Ann Surg Oncol, vol. 29, no. 11, Oct. 2022, pp. 7045–46. Pubmed, doi:10.1245/s10434-022-12293-7.

Shannon AB, Straker RJ, Carr MJ, Sun J, Landa K, Baecher K, Lynch K, Bartels HG, Panchaud R, Keele LJ, Lowe MC, Slingluff CL, Jameson MJ, Tsai KY, Faries MB, Beasley GM, Sondak VK, Karakousis GC, Zager JS, Miura JT. ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Ann Surg Oncol. 2022 Oct;29(11):7045–7046.